RIBER : 2016 first-quarter revenues
2016 first-quarter revenues
Bezons, April 21st, 2016 - 5:45 pm - RIBER, the global specialist for molecular beam epitaxy (MBE), is reporting €1.4 million in revenues for the first quarter of 2016. The order book at end-March is up 176% from the first quarter of 2015.
Business developments
| At March 31st (€'000,000) | 2016 | 2015 | Change |
| Systems | 0 | 1.5 | -100% |
| Services and accessories | 1.0 | 0.9 | +11% |
| Cells and sources | 0.4 | 0.3 | +33% |
| Total reported revenues | 1.4 | 2.7 | -52% |
While no revenues were recorded for MBE systems in the first quarter of 2016, this reflects a delivery schedule for system orders that is focused on the second part of the year and is not indicative of the Company's performance over the full year.
Sales of services, accessories and cells (€1.4 million) show 17% growth compared with the first quarter of 2015, driven by sustained demand in the US and the good commercial performance achieved following the acquisition of MBE Control Solutions at the end of March 2015.
At March 31st, 2016, the breakdown of RIBER's revenues was as follows: Asia (30%), Europe (33%) and the United States (37%).
Change in the order book and outlook
| At March 31st (€'000,000) | 2016 | 2015 | Change |
| Systems order book | 9.5 | 2.6 | +265% |
| Services and accessories order book | 2.4 | 1.3 | +85% |
| Cells and sources order book | 0.5 | 0.7 | -28% |
| Total order book | 12.4 | 4.5 | +176% |
Following the high level of orders recorded in the second half of 2015, RIBER confirmed its dynamic commercial development in the first quarter of 2016 with an order for a production system in Asia and a research system order in Europe, highlighting the gradual upturn in its MBE business.
At March 31st, 2016, the order book represented €12.4 million, versus €4.5 million at March 31st, 2015. It comprises two production machines for delivery in 2016 (€5 million), compared with 0 in 2015, and five research systems for delivery in 2016 (€4.5 million), compared with two in 2015, as well as various orders for services, cells and sources (€2.9 million; +45%).
Next date:
-
April 26th, 2016: Ordinary General Meeting
-
April 29th, 2016: 2015 full-year earnings and publication of the 2015 annual financial report
About RIBER:
Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-tech equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to OLED flat screens and next-generation solar cells.
Riber recorded €12.8 million in revenues for 2015, with 93 employees at the end of 2015. The company is ISO9001 certified. Riber is listed on Euronext Paris (Compartment "C") and is part of the CAC Small, CAC Mid & Small, CAC Technology and CAC T. HARD. & EQ indices. Riber is eligible for SME share-based savings schemes.
ISIN: FR0000075954 - RIB
Reuters: RIBE.PA
Bloomberg: RIB: FP
BPI France-approved innovative company
|
RIBER
François Morizet tel: +33 1 39 96 65 00 invest@riber.com |
CALYPTUS
Cyril Combe tel: +33 1 53 65 68 68 cyril.combe@calyptus.net |
www.riber.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: RIBER via GlobeNewswire
